Medtronic on Tuesday released financial results for the third quarter of fiscal year 2017.
Here are three things to know.
1. Medtronic reported a 3 percent rise in net income in the third quarter of FY 2017, increasing from $1.50 billion, or $1.06 per share, in the third quarter of FY 2016 to $1.55 billion, or $1.12 per share, in the most-recent third quarter. The company attributes the rise to increased sales in its restorative therapies group and minimally invasive therapies group, among other factors.
2. The company's global revenue grew to $7.28 billion in the third quarter of FY 2017, up 5.1 percent from $6.93 billion the same period of the year prior.
3. Medtronic's generated $4.11 billion in U.S. revenue, representing 56 percent of the total revenue.
4. The company projects 2017 full year free cash flow ranging from $5 billion to $6 billion.
More articles on supply chain:
Dr. Toby Cosgrove: Drug costs contributed to Cleveland Clinic's low operating income for FY 2016
7 lessons on supply chain management from Intermountain's Richard Beach
Premier's new platform integrates supply chain analytics with clinical outcomes